Table 3.
Exposure | Case (%) n = 6541 | Control (%) n = 65410 | Crude OR | Adjusted OR † |
---|---|---|---|---|
3 months |
|
|
|
|
Non user |
6368(97.36) |
64687(98.89) |
1 |
1 |
User |
173(2.64) |
723(1.11) |
2.43(2.06-2.88) |
1.63(1.62-1.63) |
6 months |
|
|
|
|
Non user |
6306(96.41) |
64276(98.27) |
1 |
1 |
User |
235(3.59) |
1134(1.73) |
2.11(1.83-2.44) |
1.29(1.29-1.30) |
12 months |
|
|
|
|
Non user |
6221(95.11) |
63575(97.19) |
1 |
1 |
User |
320(4.89) |
1835(2.81) |
1.78(1.58-2.01) |
0.99(0.99-1.01) |
24 months |
|
|
|
|
Non user |
6103(93.30) |
62519(95.58) |
1 |
1 |
User | 438(6.70) | 2891(4.42) | 1.55(1.40-1.72) | 0.90(0.89-0.90) |
Abbreviations: OR, odds ratio. †Adjusted for socioeconomic status, congestive heart failure, coronary heart disease, chronic pulmonary disease, diabetes mellitus, end stage renal disease, liver cirrhosis, alcohol abuse, peptic ulcer disease, reflux esophagitis, gastrectomy, HIV, connective tissue disease, malignant neoplasm, organ transplantation.